Corona Remedies IPO
Corona Remedies IPO is a mainboard IPO raising ₹655 Cr at ₹1,008 – ₹1,062 a share. It listed on 15 Dec 2025 and trades at ₹2,067 today, +94.6% against its issue price of ₹1,062. It was subscribed 137× in total.
137.0 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
What happened after it listed
Computed from our own daily closes — never from the exchange’s listing-price field, which is missing for about 47% of listed issues.
Multi-horizon returns — listing day, one week, one month, three, six and a year — are being built and will appear here.
How its cohort has done
103 mainboard issues listed in 2025 that we can price today. This is the group this issue belongs to.
Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →
Everything this company files, from here on
A newly listed company starts filing results, orders and board decisions immediately. We summarise each one and send it to your WhatsApp.